Scientists have identified two drugs that are potent against acute myeloid leukemia (AML) when combined, but only weakly effective when used alone. The researchers were able to significantly enhance cancer cell death by jointly administering the drugs that are only partially effective when used as single-agent therapies.
- Variable compensation and salesperson health
- Beauty is in the brain: AI reads brain data, generates personally attractive images
- Overweight children exposed to lead in utero may have poor future kidney function
- Why we’re so bad at daydreaming, and how to fix it
- Team of bioethicists and scientists suggests revisiting 14-day limit on human embryo